Subdissociative intranasal ketamine plus standard pain therapy versus standard pain therapy in the treatment of paediatric sickle cell disease vaso-occlusive crises in …
JR Young, HR Sawe, JA Mfinanga, E Nshom, E Helm… - BMJ open, 2017 - bmjopen.bmj.com
Introduction Pediatric sickle cell disease, highly prevalent in sub-Saharan Africa, carries
great morbidity and mortality risk. Limited resources and monitoring make management of …
great morbidity and mortality risk. Limited resources and monitoring make management of …